Agencies News Topics Contact The FDA has authorized booster doses of all three U.S. COVID-19 vaccines for fully vaccinated adults. More Info TESTING UPDATES PREVENTION INFLUENZA CONTACT ESP HC Home COVID-19 Vaccine Need a Booster, 2nd, or 3rd Dose? Listen Need a Booster, 2nd, or 3rd Dose? Use the navigation to jump to the section of the page you want to go to. Delaware Division of Public Health follows CDC guidance and FDA approvals, so after these agencies make new announcements, this page will be updated. Menu: Booster Doses Additional (Third) Doses Second Doses Am I Eligible for a Booster Dose? You are eligible for a booster dose if: You are 18 and older and; it has been at least 6 months after your second dose of the Pfizer or Moderna vaccines; it has been at least 2 months after you received the Johnson & Johnson (J&J) vaccine. According to the CDC, the J&J vaccine after one dose has lower effectiveness compared to the Pfizer and Moderna. You qualified for an “additional/third” dose of Pfizer or Moderna because you have certain immunocompromising conditions (listed below under Additional (Third) Doses section). You can get your booster (fourth) dose 6 months after receiving your additional/third dose. Fact Sheet: Am I eligible for a COVID-19 booster? You may choose which vaccine you want to receive as a booster dose. CDC’s recommendations now allow for this type of mix and match dosing for booster shots. The Moderna booster is half the dosage of that given as a first or second dose. If you recently had COVID-19 but want to get your booster, you only need to wait until you are cleared from quarantine or isolation to get it. Where Can I Get a Booster Dose? For a complete list of locations where vaccines are available, visit de.gov/getmyvaccine. If you’re looking for a specific vaccine brand, use the search on vaccines.gov that can help you find a location with that brand in stock. Those who are eligible for a booster shot are recommended to seek vaccine at existing vaccine sites including pharmacies, health care providers, Federally Qualified Health Centers (for patients), and the following standing DPH Vaccine sites: Blue Hen Corporate Center: 655 S. Bay Road, Dover, DE 19901 Georgetown Plaza: 19 Georgetown Plaza, Georgetown, DE 19947 Canby Park: 1920 Maryland Ave., Wilmington, DE 19805 University Plaza, 256 Chapman Road, Suite 100, Newark, DE 19702 Additional (Third) Doses Pfizer-BioNTech or Moderna COVID-19 vaccine The U.S. Food and Drug Administration (FDA) has amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the administration of an additional dose in certain immunocompromised individuals. Emerging data suggest some people with moderately to severely compromised immune systems do not always build the same level of immunity compared to people who are not immunocompromised, and as a result may benefit from a third dose of the mRNA vaccines. Providers may administer a third dose of either the Pfizer or Moderna vaccines to individuals in the following categories who received either vaccine the first time: Recipients of organ or stem cell transplants People with advance or untreated HIV infection Active recipients of treatment for cancer People who are taking some medications that weaken the immune system On Sept. 10, the Delaware Division of Public Health issued a Health Update for physicians reminding them that they may use clinical judgment and consider additional factors when determining a person’s level of immunocompetence (being immunocompromised) – and whether they may benefit from a third dose of Pfizer or Moderna. Providers may consider advanced age, particularly 85 years and older, residency in a long-term care facility, residency in a congregate setting, or debilitating disease and comorbidities as additional factors. *Age or residency in a congregate setting alone should not be considered a determining factor for being immunocompromised. The third mRNA dose may only be administered at least four weeks (28 days) after completing the original two-dose vaccine series. The CDC also recommends a booster dose (fourth shot), 6 months after receiving a third dose for these individuals. Johnson & Johnson COVID-19 vaccine Individuals 18 years and older who initially received the Johnson & Johnson COVID-19 vaccine are not eligible for an “Additional” dose under these conditions, but are eligible for a booster dose of any of the three approved vaccines two months after receiving their initial dose. People who meet any of these categories are encouraged to contact their primary care or specialty care provider with questions or for a vaccine. If your provider is not administering vaccines, you may go to any pharmacy or DPH Vaccination clinic for a third dose. While you do not need to provide written proof of your condition, you must self-attest that you meet the conditions. Visit de.gov/getmyvaccine for a list of vaccination sites. For more information, visit https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html Report Vaccination Violations Submit complaints about a vaccination provider by using this form, if you think they are violating any of these requirements. Get More COVID Data For more data on Delaware COVID cases, testing and outcomes, including demographic breakdowns, go to My Healthy Community YouTube Related Topics: COVID-19 Vaccine, Second Doses, Vaccine Delaware Division of Public Health, Coronavirus Response Testing Vaccine Data Coronavirus News Frequently Asked Questions Community Resources Contact +